A detailed history of Raymond James & Associates transactions in Neuberger Berman High Yield Strategies Fund Inc. stock. As of the latest transaction made, Raymond James & Associates holds 16,072 shares of NHS stock, worth $123,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,072
Previous 12,072 33.13%
Holding current value
$123,432
Previous $94,000 47.87%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$7.9 - $8.67 $31,600 - $34,680
4,000 Added 33.13%
16,072 $139,000
Q2 2024

Jul 19, 2024

SELL
$7.82 - $8.13 $54 - $56
-7 Reduced 0.06%
12,072 $94,000
Q1 2023

Apr 14, 2023

SELL
$7.82 - $9.32 $6,349 - $7,567
-812 Reduced 6.3%
12,079 $102,000
Q4 2022

Feb 08, 2023

SELL
$7.46 - $9.13 $23,730 - $29,042
-3,181 Reduced 19.79%
12,891 $109,000
Q3 2022

Oct 25, 2022

SELL
$7.76 - $9.74 $39,576 - $49,674
-5,100 Reduced 24.09%
16,072 $127,000
Q1 2022

May 11, 2022

SELL
$10.26 - $12.52 $14,497 - $17,690
-1,413 Reduced 6.26%
21,172 $242,000
Q3 2021

Nov 02, 2021

SELL
$12.47 - $13.53 $3,990 - $4,329
-320 Reduced 1.4%
22,585 $286,000
Q2 2021

Aug 11, 2021

SELL
$12.6 - $13.51 $13,494 - $14,469
-1,071 Reduced 4.47%
22,905 $304,000
Q4 2020

Feb 12, 2021

SELL
$10.75 - $12.04 $119,615 - $133,969
-11,127 Reduced 31.7%
23,976 $280,000
Q3 2020

Nov 04, 2020

SELL
$10.47 - $11.46 $19,306 - $21,132
-1,844 Reduced 4.99%
35,103 $389,000
Q2 2020

Jul 28, 2020

BUY
$8.3 - $11.13 $6,880 - $9,226
829 Added 2.3%
36,947 $382,000
Q1 2020

Apr 21, 2020

SELL
$7.14 - $12.72 $47,502 - $84,626
-6,653 Reduced 15.55%
36,118 $314,000
Q4 2019

Feb 12, 2020

SELL
$11.81 - $12.38 $87,181 - $91,389
-7,382 Reduced 14.72%
42,771 $528,000
Q3 2019

Nov 07, 2019

SELL
$11.57 - $12.09 $345,619 - $361,152
-29,872 Reduced 37.33%
50,153 $605,000
Q2 2019

Aug 06, 2019

SELL
$11.36 - $11.97 $299,120 - $315,182
-26,331 Reduced 24.76%
80,025 $936,000
Q1 2019

May 06, 2019

BUY
$9.65 - $11.36 $48,028 - $56,538
4,977 Added 4.91%
106,356 $1.2 Million
Q4 2018

Feb 11, 2019

SELL
$9.19 - $11.0 $194,442 - $232,738
-21,158 Reduced 17.27%
101,379 $980,000
Q3 2018

Nov 14, 2018

SELL
$10.79 - $11.0 $68,764 - $70,103
-6,373 Reduced 4.94%
122,537 $1.34 Million
Q2 2018

Aug 14, 2018

BUY
$10.82 - $11.18 $175,208 - $181,037
16,193 Added 14.37%
128,910 $1.4 Million
Q1 2018

May 14, 2018

BUY
$10.97 - $11.83 $47,620 - $51,354
4,341 Added 4.01%
112,717 $1.26 Million
Q4 2017

Feb 14, 2018

BUY
$11.4 - $12.3 $56,167 - $60,602
4,927 Added 4.76%
108,376 $1.28 Million
Q3 2017

Nov 13, 2017

BUY
$11.83 - $12.17 $189,350 - $194,793
16,006 Added 18.3%
103,449 $1.26 Million
Q2 2017

Aug 14, 2017

BUY
N/A
87,443
87,443 $1.04 Million

Others Institutions Holding NHS

About Neuberger Berman High Yield Strategies Fund Inc.


  • Ticker NHS
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equ...
More about NHS
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.